Ionis Pharmaceuticals Inc
(FRA:ISI)
€
35.48
-0.1 (-0.28%)
Market Cap: 5.67 Bil
Enterprise Value: 5.08 Bil
PE Ratio: 0
PB Ratio: 21.27
GF Score: 59/100 Ionis Pharmaceuticals Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 26, 2021 / 04:20PM GMT
Release Date Price:
€43.76
(-0.97%)
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
Hello, everyone, and welcome back to the next session in our suite of presentations for our 10th Annual Global Healthcare Conference. I'm Mani Foroohar, senior analyst for our genetic medicines team, and I'm fortunate to host Eric Swayze and Wade Walke from Ionis Pharmaceuticals. How are you guys doing today?
Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research
Doing Great. Glad to be here. Thanks for the opportunity.
Questions & Answers
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
Okay. So I want to start just by working through some of the sort of key questions around the pipeline you guys have already reported for the quarter. So those numbers are already out. So we can just dive into the science. For those in the investment -- in the investor audience, if you have any specific questions, things you wanted us to follow-up on,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot